More immunosuppressive, more immunotherapy responsive? A double-edged sword of HBV-induced immune response in HCC. Huang CH, Hsieh SY. Hepatology 2023;78:706-708.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang CH, Hsieh SY. More immunosuppressive, more immunotherapy responsive? A double-edged sword of HBV-induced immune response in HCC. Hepatology 2023;78:706-708.
PMID: 37013921